deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT03944512

Pravastatin to Prevent Preeclampsia (Pravastatin)

A Randomized Controlled Trial of Pravastatin to Prevent Preeclampsia in High Risk Women

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Updated 18 times since 2019 Last updated: Dec 9, 2025 Started: Jul 17, 2019 Primary completion: Jun 6, 2021 Completion: Jun 20, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

participants are no longer being examined or receiving intervention

Other Hypertension in Pregnancy trials with similar outcome

Browse all Hypertension in Pregnancy trials

A PHASE3 clinical study on Hypertension in Pregnancy and Obstetric Labor Complications, this trial is terminated or withdrawn. The trial is conducted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and has accumulated 18 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jun 2019 – ~Aug 2019 · 2 months · monthly snapshot~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshot~Dec 2019 – ~Mar 2020 · 3 months · monthly snapshot~Mar 2020 – ~May 2020 · 2 months · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Jul 2022 · 9 months · monthly snapshot~Jul 2022 – ~Jan 2023 · 6 months · monthly snapshot~Jan 2023 – ~Oct 2023 · 9 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshot~Jan 2026 – present · 8 months · monthly snapshot

Change History

18 versions recorded
  1. Jan 2026 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Jan 2026 [monthly]

    Terminated PHASE3

  3. Aug 2024 — Sep 2024 [monthly]

    Terminated PHASE3

    Status: Active Not RecruitingTerminated

  4. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting PHASE3

  5. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

Show 13 earlier versions
  1. Jan 2023 — Oct 2023 [monthly]

    Active Not Recruiting PHASE3

  2. Jul 2022 — Jan 2023 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  3. Oct 2021 — Jul 2022 [monthly]

    Recruiting PHASE3

  4. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

  5. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE3

  6. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  7. Aug 2020 — Nov 2020 [monthly]

    Recruiting PHASE3

  8. Jul 2020 — Aug 2020 [monthly]

    Recruiting PHASE3

    Status: Active Not RecruitingRecruiting

  9. May 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  10. Mar 2020 — May 2020 [monthly]

    Recruiting PHASE3

  11. Dec 2019 — Mar 2020 [monthly]

    Recruiting PHASE3

  12. Aug 2019 — Dec 2019 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  13. Jun 2019 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Heart, Lung, and Blood Institute (NHLBI)
  • The George Washington University Biostatistics Center
Data source: The George Washington University Biostatistics Center

For direct contact, visit the study record on ClinicalTrials.gov .